Drug notes:
P-MUC1C-ALL01 Clin1 solid tumors; P-CD19CD20-ALLO1 Clin1 B-cell malignancies (partner: Roche); 4 programs Clin0 multiple cancers; P-OTC-101 Clin0 OTC deficiency; P-FVIII-101 Clin0 hemophilia A; P-PAH-101 Clin0 phenylketonuria
About:
Poseida Therapeutics is developing next-generation gene engineering technologies. Using their proprietary genetic engineering platform combining the piggyBac DNA Modification System, Cas-CLOVER Gene Editing System and Nanparticle/AAV Delivery Technology, Poseida is developing single treatment cures that efficiently deliver genetic cargo into cells. Poseida’s gene engineering technologies represent the next wave of innovation and brings hope to patients with cancer and genetic disease. Poseida is advancing product candidates including CAR-T therapies to harness the power of a patient’s own immune system.
Jobs:
Senior Director, Partnership Finance San Diego, CA|Not provided
Senior Vice President, Business Development San Diego, CA|Not provided
Research Scientist/Research Scientist II/Senior Re... San Diego, CA|Not provided
Quality Specialist II (GMP) San Diego, CA|Not provided
Data Scientist, Process Development San Diego, CA|Not provided
Senior Process Development Associate San Diego, CA|Not provided
Process Development Scientist San Diego, CA|Not provided
Process Development Scientist II San Diego, CA|Not provided
Senior Process Development Associate - MSAT San Diego, CA|Not provided